{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:52:56Z","timestamp":1789901576517,"version":"4.0.1"},"reference-count":35,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2013,1,27]],"date-time":"2013-01-27T00:00:00Z","timestamp":1359244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,1,27]],"date-time":"2013-01-27T00:00:00Z","timestamp":1359244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/jcpt.12039","type":"journal-article","created":{"date-parts":[[2013,1,27]],"date-time":"2013-01-27T19:17:38Z","timestamp":1359314258000},"page":"115-120","source":"Crossref","is-referenced-by-count":26,"title":["Drug-induced liver injury in the Australian setting"],"prefix":"10.1155","volume":"38","author":[{"given":"M.","family":"Sistanizad","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy; School of Pharmacy; Shahid Beheshti Medical University; Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Peterson","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Unit for Medication Outcomes Research and Education (UMORE); University of Tasmania; Hobart Tasmania Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,1,27]]},"reference":[{"key":"10.1111\/jcpt.12039-BIB0001|jcpt12039-cit-0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","article-title":"Drug-induced liver diseases","volume":"32","author":"Larrey","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12039-BIB0002|jcpt12039-cit-0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish committee on adverse drug reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J Intern Med"},{"key":"10.1111\/jcpt.12039-BIB0003|jcpt12039-cit-0003","first-page":"315","article-title":"Drug associated hepatic reactions in New Zealand: 21\u00a0years experience","volume":"109","author":"Pillans","year":"1996","journal-title":"N Z Med J"},{"key":"10.1111\/jcpt.12039-BIB0004|jcpt12039-cit-0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-004-0888-z","article-title":"Incidence of drug-induced liver injury in medical inpatients","volume":"6","author":"Meier","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12039-BIB0005|jcpt12039-cit-0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the US","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/jcpt.12039-BIB0006|jcpt12039-cit-0006","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Av Klinteberg V, Alem N, Olsson R, Bjornsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jcpt.12039-BIB0007|jcpt12039-cit-0007","first-page":"77","article-title":"Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation","volume":"30","author":"Jmelnitzky","year":"2000","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1111\/jcpt.12039-BIB0008|jcpt12039-cit-0008","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0009-9236(95)90078-0","article-title":"Drug safety discontinuations in UK, US, and Spain from 1974 through 1993: a regulatory perspective","volume":"58","author":"Bakke","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12039-BIB0009|jcpt12039-cit-0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1081\/DMR-120034148","article-title":"Clinical perspectives on xenobiotic-induced hepatotoxicity","volume":"36","author":"Gunawan","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1111\/jcpt.12039-BIB0010|jcpt12039-cit-0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/jhep.2001.23505","article-title":"Drug-induced liver injury: mechanisms and test systems","volume":"33","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12039-BIB0011|jcpt12039-cit-0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12039-BIB0012|jcpt12039-cit-0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3748\/wjg.v13.i3.329","article-title":"Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists","volume":"13","author":"Andrade","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0013|jcpt12039-cit-0013","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/jcpt.12039-BIB0014|jcpt12039-cit-0014","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.3748\/wjg.15.2817","article-title":"Drug-induced liver injury: is it somehow foreseeable?","volume":"15","author":"Tarantino","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0015|jcpt12039-cit-0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/jhep.2001.21083","article-title":"Causality assessment vs. guilt-by-association in drug hepatotoxicity","volume":"33","author":"Kaplowitz","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12039-BIB0016|jcpt12039-cit-0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12039-BIB0017|jcpt12039-cit-0017","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12039-BIB0018|jcpt12039-cit-0018","first-page":"926","article-title":"Comparison and analysis of two international diagnostic criteria for the diagnosis of 230 cases with drug-induced liver injury","volume":"15","author":"Xu","year":"2007","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1111\/jcpt.12039-BIB0019|jcpt12039-cit-0019","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2036.2008.03655.x","article-title":"Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury","volume":"27","author":"Garcia-Cortes","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jcpt.12039-BIB0020|jcpt12039-cit-0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12039-BIB0021|jcpt12039-cit-0021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1590-8658(00)80336-9","article-title":"Spontaneous reporting of drug-related hepatic reactions from two Italian regions (Lombardy and Veneto)","volume":"32","author":"Conforti","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1111\/jcpt.12039-BIB0022|jcpt12039-cit-0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00365528209182041","article-title":"Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish board of adverse reactions to Drugs","volume":"17","author":"Dossing","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0023|jcpt12039-cit-0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1751-2980.2009.00385.x","article-title":"Drug-induced liver disease: an 8-year study of patients from one gastroenterological department","volume":"10","author":"Wang","year":"2009","journal-title":"J Dig Dis"},{"key":"10.1111\/jcpt.12039-BIB0024|jcpt12039-cit-0024","first-page":"64","article-title":"The burden of acute nonfulminant drug-induced hepatitis in a US tertiary referral center [corrected]","volume":"39","author":"Galan","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0025|jcpt12039-cit-0025","first-page":"655","volume-title":"Pharmacotherapy: a Patophysiologic Approach","author":"Kirchain","year":"2008"},{"key":"10.1111\/jcpt.12039-BIB0026|jcpt12039-cit-0026","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MOG.0b013e3283383c7c","article-title":"Drug-induced liver injury: a clinical update","volume":"26","author":"Ghabril","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0027|jcpt12039-cit-0027","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/ajg.2010.287","article-title":"Single-center experience with drug-induced liver injury from india: causes, outcome, prognosis, and predictors of mortality","volume":"105","author":"Devarbhavi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/jcpt.12039-BIB0028|jcpt12039-cit-0028","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/jcpt.12039-BIB0029|jcpt12039-cit-0029","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2125.2005.02370.x","article-title":"Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database","volume":"60","author":"Russmann","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12039-BIB0030|jcpt12039-cit-0030","first-page":"81","article-title":"Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?","volume":"49","author":"Devereaux","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12039-BIB0031|jcpt12039-cit-0031","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0168-8278(02)00231-3","article-title":"Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs","volume":"37","author":"Ibanez","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12039-BIB0032|jcpt12039-cit-0032","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1056\/NEJM200311133492021","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Andrade","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12039-BIB0033|jcpt12039-cit-0033","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12039-BIB0034|jcpt12039-cit-0034","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.20215","article-title":"HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease","volume":"39","author":"Andrade","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12039-BIB0035|jcpt12039-cit-0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Garcia Rodriguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study","volume":"58","author":"Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12039","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12039\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:43Z","timestamp":1671818683000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,27]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12039","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,27]]}}}